As the global HIV response faces rising risks, UNAIDS shifts to a leaner, sharper model focused on country impact . GENEVA, 10 May 2025—In the face of continued high numbers of ...

Modern HIV medicine is based on a common genetic mutation. Now, researchers have traced where and when the mutation arose -- and how it protected our ancestors from ancient diseases.

Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.

A panelist discusses how a new drug combination of doravirine and islatravir was compared to a standard bictegravir-based ...

The drugs, called NRTIs, have the potential to prevent a million cases of Alzheimer's every year, the researchers believe.

UVA scientists are calling for clinical trials to see if common HIV drugs could prevent up to 1 million new Alzheimer’s cases ...

A disruption in federal funds has jeopardized HIV testing and outreach in the U.S. South, and researchers warn of a ...

South Africa’s government said its HIV-AIDS treatment program is fully funded for the current financial year despite the ...

Even after decades of research, there is no cure for the disease HIV causes, AIDS. But lenacapavir, born out of research on ...

Millions of people could die prematurely because of funding cuts to the United Nations agency tasked with tackling HIV and ...

According to a recently published survey by International Network of People who Use Drugs (INPUD) there has been large-scale suspension of outreach and harm reduction programmes, including needle and ...